(Q41757707)

8 October 2017

1 reference

title

Management of nonsteroidal anti-inflammatory drug-associated lesions: a cost-effectiveness perspective (English)

1 reference

8 October 2017

B Jönsson

1

1 reference

8 October 2017

P Wahlqvist

series ordinal

2

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

American Journal of Medicine

8 October 2017

published in

1 reference

8 October 2017

volume

104

1 reference

8 October 2017

issue

3A

1 reference

8 October 2017

page(s)

81S-88S

1 reference

Nonsteroidal anti-inflammatory drugs--another look

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900218-0

Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900218-0

New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900218-0

Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900218-0

In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900218-0

Costs, effects and C/E-ratios alongside a clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900218-0

Confidence intervals for cost/effectiveness ratios

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900218-0

Statistical analysis in pharmacoeconomic studies. A review of current issues and standards.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900218-0

Issues in the cross-national assessment of health technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900218-0

Cost-effectiveness of misoprostol in Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900218-0

Outcome measurement in economic evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900218-0

10.1016/S0002-9343(97)00218-0

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference